Literature DB >> 11226218

pRB induces Sp1 activity by relieving inhibition mediated by MDM2.

T Johnson-Pais1, C Degnin, M J Thayer.   

Abstract

pRB activates transcription by a poorly understood mechanism that involves relieving negative regulation of the promoter specificity factor Sp1. We show here that MDM2 inhibits Sp1-mediated transcription, that MDM2 binds directly to Sp1 in vitro as well as in vivo, and that MDM2 inhibits the DNA-binding activity of Sp1. Forced expression of pRB relieves MDM2-mediated repression, and interaction of pRB with the MDM2-Sp1 complex releases Sp1 and restores DNA binding. These results suggest a model in which the opposing activities of MDM2 and pRB regulate Sp1 DNA-binding and transcriptional activity.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11226218      PMCID: PMC30117          DOI: 10.1073/pnas.051415898

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  34 in total

1.  Cell cycle-regulated association of E2F1 and Sp1 is related to their functional interaction.

Authors:  S Y Lin; A R Black; D Kostic; S Pajovic; C N Hoover; J C Azizkhan
Journal:  Mol Cell Biol       Date:  1996-04       Impact factor: 4.272

2.  Interaction of Sp1 with the growth- and cell cycle-regulated transcription factor E2F.

Authors:  J Karlseder; H Rotheneder; E Wintersberger
Journal:  Mol Cell Biol       Date:  1996-04       Impact factor: 4.272

3.  A unique cathepsin-like protease isolated from CV-1 cells is involved in rapid degradation of retinoblastoma susceptibility gene product, RB, and transcription factor SP1.

Authors:  T Nishinaka; Y H Fu; L I Chen; K Yokoyama; R Chiu
Journal:  Biochim Biophys Acta       Date:  1997-04-10

4.  Negative regulation of Sp1 trans-activation is correlated with the binding of cellular proteins to the amino terminus of the Sp1 trans-activation domain.

Authors:  Y Murata; H G Kim; K T Rogers; A J Udvadia; J M Horowitz
Journal:  J Biol Chem       Date:  1994-08-12       Impact factor: 5.157

5.  Regulation of p53 stability by Mdm2.

Authors:  M H Kubbutat; S N Jones; K H Vousden
Journal:  Nature       Date:  1997-05-15       Impact factor: 49.962

6.  Mdm2 promotes the rapid degradation of p53.

Authors:  Y Haupt; R Maya; A Kazaz; M Oren
Journal:  Nature       Date:  1997-05-15       Impact factor: 49.962

7.  Amplification of MDM2 inhibits MyoD-mediated myogenesis.

Authors:  T A Fiddler; L Smith; S J Tapscott; M J Thayer
Journal:  Mol Cell Biol       Date:  1996-09       Impact factor: 4.272

8.  The retinoblastoma-susceptibility gene product binds directly to the human TATA-binding protein-associated factor TAFII250.

Authors:  Z Shao; S Ruppert; P D Robbins
Journal:  Proc Natl Acad Sci U S A       Date:  1995-04-11       Impact factor: 11.205

9.  Interaction between the retinoblastoma protein and the oncoprotein MDM2.

Authors:  Z X Xiao; J Chen; A J Levine; N Modjtahedi; J Xing; W R Sellers; D M Livingston
Journal:  Nature       Date:  1995-06-22       Impact factor: 49.962

10.  Stimulation of E2F1/DP1 transcriptional activity by MDM2 oncoprotein.

Authors:  K Martin; D Trouche; C Hagemeier; T S Sørensen; N B La Thangue; T Kouzarides
Journal:  Nature       Date:  1995-06-22       Impact factor: 49.962

View more
  10 in total

1.  High-level Sp1 is Associated with Proliferation, Invasion, and Poor Prognosis in Astrocytoma.

Authors:  Yi-Ting Chen; Hung-Pei Tsai; Chun-Chieh Wu; Chiao-Yun Chen; Chee-Yin Chai; Aij-Lie Kwan
Journal:  Pathol Oncol Res       Date:  2018-06-09       Impact factor: 3.201

2.  P14ARF inhibits human glioblastoma-induced angiogenesis by upregulating the expression of TIMP3.

Authors:  Abdessamad Zerrouqi; Beata Pyrzynska; Maria Febbraio; Daniel J Brat; Erwin G Van Meir
Journal:  J Clin Invest       Date:  2012-03-01       Impact factor: 14.808

3.  Delayed replication timing leads to delayed mitotic chromosome condensation and chromosomal instability of chromosome translocations.

Authors:  L Smith; A Plug; M Thayer
Journal:  Proc Natl Acad Sci U S A       Date:  2001-11-06       Impact factor: 11.205

4.  Evidence that the human cytomegalovirus IE2-86 protein binds mdm2 and facilitates mdm2 degradation.

Authors:  Zhigang Zhang; David L Evers; Joseph F McCarville; Jean-Christophe Dantonel; Shu-Mei Huong; Eng-Shang Huang
Journal:  J Virol       Date:  2006-04       Impact factor: 5.103

Review 5.  The RB tumor suppressor at the intersection of proliferation and immunity: relevance to disease immune evasion and immunotherapy.

Authors:  Jack Hutcheson; Agnieszka K Witkiewicz; Erik S Knudsen
Journal:  Cell Cycle       Date:  2015       Impact factor: 4.534

6.  Splicing up mdm2 for cancer proteome diversity.

Authors:  Danielle R Okoro; Melissa Rosso; Jill Bargonetti
Journal:  Genes Cancer       Date:  2012-03

7.  Role of the E1A Rb-binding domain in repression of the NF-kappa B-dependent defense against tumor necrosis factor-alpha.

Authors:  James L Cook; Thomas A Walker; G Scott Worthen; Jay R Radke
Journal:  Proc Natl Acad Sci U S A       Date:  2002-07-15       Impact factor: 11.205

8.  MDM2 negatively regulates the human telomerase RNA gene promoter.

Authors:  Jiangqin Zhao; Alan Bilsland; Katrina Jackson; W Nicol Keith
Journal:  BMC Cancer       Date:  2005-01-18       Impact factor: 4.430

9.  A Novel Interaction between TFII-I and Mdm2 with a Negative Effect on TFII-I Transcriptional Activity.

Authors:  Kateřina Cetkovská; Hana Šustová; Pavlína Kosztyu; Stjepan Uldrijan
Journal:  PLoS One       Date:  2015-12-11       Impact factor: 3.240

10.  Murine double minute 2, a potential p53-independent regulator of liver cancer metastasis.

Authors:  Atul Ranjan; Kaustav Bera; Tomoo Iwakuma
Journal:  Hepatoma Res       Date:  2016-05-06
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.